PODD

Insulet Corporation
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$10.91B
P/E Ratio
37.76
EPS
$4.17
Beta
1.11
52W High
$354.88
52W Low
$138.79
50-Day MA
$154.79
200-Day MA
$245.27
Dividend Yield
Profit Margin
10.40%
Forward P/E
25.71
PEG Ratio
1.41

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.90B
Gross Profit (TTM)$2.06B
EBITDA$602.00M
Operating Margin16.00%
Return on Equity23.00%
Return on Assets9.74%
Revenue/Share (TTM)$41.28
Book Value$18.81
Price-to-Book8.50
Price-to-Sales (TTM)3.86
EV/Revenue3.976
EV/EBITDA20.45
Quarterly Earnings Growth (YoY)159.00%
Quarterly Revenue Growth (YoY)33.90%
Shares Outstanding$69.27M
Float$68.99M
% Insiders0.33%
% Institutions105.45%

Historical Volatility

HV 10-Day
48.15%
HV 20-Day
51.25%
HV 30-Day
49.43%
HV 60-Day
57.42%
HV Rank
86.5%

Volatility is currently contracting

Analyst Ratings

Consensus ($239.42 target)
4
Strong Buy
18
Buy
3
Hold

Latest News

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure Levels NEW YORK, July 9, 2026 /PRNewswire/ -- Institutional investors holding positions in Insulet Corporation (NASDAQ: PODD) during the period from February 21, 2025 through May 26, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.

PRNewsWire7/9/2026Neutral
Deadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, July 09, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”).

GlobeNewsWire7/9/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Insulet securities between May 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire7/9/2026Neutral
Here's Why Insulet (PODD) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research7/9/2026Positive
INSULET CORPORATION (PODD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Insulet Corporation Investors of Upcoming Deadline

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) of the  August 31, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Insulet Class Action Lawsuit : Do you, or did you, own shares of Insulet Corporation (NASDAQ: PODD)?

GlobeNewsWire7/9/2026Neutral
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODD

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 31, 2026.

GlobeNewsWire7/9/2026Neutral
ROSEN, A LONGSTANDING FIRM, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODD

New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

Newsfile Corp7/9/2026Neutral
Levi & Korsinsky Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026 - PODD

Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections Affecting Millions of Pods NEW YORK, July 8, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP examines the adequacy of Insulet Corporation's (NASDAQ: PODD) risk disclosures during the Class Period of February 21, 2025 through May 26, 2026. A securities class action has been filed alleging that Insulet's public filings contained materially misleading statements about manufacturing quality while defective controls at the Company's Acton, Massachusetts facility went undisclosed.

PRNewsWire7/8/2026Neutral
INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of Securities Class Action Lawsuit Deadline on August 31, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Insulet between February 21, 2025 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 8, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp7/8/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Insulet securities between May 21, 2025 and May 26, 2026, both dates inclusive (the "Class Period").

Newsfile Corp7/8/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026